Tetragon Partners GP Ltd
Tetragon Partners GP Ltd reported 41 holdings worth US$766M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Tetragon Partners GP Ltd reported 41 holdings worth US$766M as of Sep 30, 2026. Largest: UiPath, Inc., Kolibri Global Energy Inc and Silence Therapeutics PLC. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 41
- Value as reported
- US$766M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| UiPath, Inc. | 32.5M | US$417M | 54.5% |
| Kolibri Global Energy Inc | 6.83M | US$42.3M | 5.5% |
| Silence Therapeutics PLC | 2.44M | US$26.6M | 3.5% |
| Ionis Pharmaceuticals, Inc. | 441K | US$19.7M | 2.6% |
| Autolus Therapeutics plc | 9.5M | US$18.4M | 2.4% |
| Arrowhead Pharmaceuticals, Inc. | 264K | US$17.3M | 2.3% |
| Lyft, Inc. | 1M | US$15M | 2.0% |
| Workiva Inc. | 225K | US$15M | 2.0% |
| MBX Biosciences, Inc. | 221K | US$12.9M | 1.7% |
| Definium Therapeutics, Inc. | 311K | US$11.8M | 1.5% |
| Sprinklr, Inc. | 2.2M | US$10.9M | 1.4% |
| Celldex Therapeutics, Inc. | 296K | US$9.59M | 1.3% |
| Immunovant, Inc. | 275K | US$9.3M | 1.2% |
| Harmony Biosciences Holdings, Inc. | 227K | US$8.9M | 1.2% |
| Alkami Technology, Inc. | 650K | US$8.9M | 1.2% |
| Dyne Therapeutics, Inc. | 511K | US$8.24M | 1.1% |
| Relay Therapeutics, Inc. | 447K | US$8.07M | 1.1% |
| Agios Pharmaceuticals, Inc. | 216K | US$7.17M | 0.94% |
| Celcuity Inc. | 87,421 | US$6.95M | 0.91% |
| Neurocrine Biosciences, Inc. | 47,014 | US$6.67M | 0.87% |
| Krystal Biotech, Inc. | 19,668 | US$6.54M | 0.85% |
| Axsome Therapeutics, Inc. | 35,000 | US$6.45M | 0.84% |
| Warner Bros. Discovery, Inc. - Series A | 200K | US$6.19M | 0.81% |
| Nektar Therapeutics | 102K | US$6.15M | 0.80% |
| Uber Technologies, Inc. | 71,428 | US$4.89M | 0.64% |
| Snowflake Inc. | 10,000 | US$3.4M | 0.44% |
| AN2 Therapeutics, Inc. | 603K | US$3.21M | 0.42% |
| Annexon, Inc. | 656K | US$2.77M | 0.36% |
| Monte Rosa Therapeutics, Inc. | 56,052 | US$669K | 0.09% |
| Tectonic Therapeutic, Inc. | 26,798 | US$624K | 0.08% |
| ACADIA Pharmaceuticals Inc. | 0 | US$0 | 0.00% |
| Aclaris Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Amylyx Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Cue Biopharma, Inc. | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC
Related